Order Entry
Northern Ireland
ContactUsLinkComponent
Human recombinant VEGF121 (from HEK293 cells)
Human recombinant VEGF121 (from HEK293 cells)
Catalog # PRSI96-768
Supplier:  ProSci Inc.
CAS Number:  
undefined
Human recombinant VEGF121 (from HEK293 cells)
Catalog # PRSI96-768
Supplier:  ProSci Inc.
CAS Number:  

Some Products May Appear Restricted

To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.

If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/us/en/login/register)

 

If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation;  additional documentation will be requested for these items prior to shipment. 

Specifications

  • Pk:
    20 µG
  • Protein/peptide type:
    Recombinant
  • Source:
    HEK293 cells
  • Species:
    Human
  • Biological activity:
    Measured by its binding ability in a functional ELISA.
    Immobilized ActiveMax® Human VEGF121 at 2 ug/mL can bind Human VEGF R2, Strep Tag with a linear range of 0.15-2.5 ug/mL.
  • Protein synonyms:
    VEGF121|RP1-261G23.1|MVCD1|VEGF|MGC70609|VEGFA|VPF
  • Protein/peptide name:
    VEGF121
  • Purity:
    >95% as determined by SDS-PAGE of reduced (+) and non-reduced (-) rhVEGF121.
  • Molecular weight:
    14 kDa (monomer)
  • Formulation:
    Lyophilized, PBS, pH7.4
  • Tested applications:
    Western Blot

Specifications

About this item

Vascular endothelial growth factor (VEGF) is also known as vascular permeability factor (VPF) and VEGF-A, and is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized.

Alternatively spliced isoforms of 121,145,165,183,189 and 206 amino acids in length are expressed in humans. VEGF165 appears to be the most abundant and potent isoform, followed by VEGF121 and VEGF189. VEGF121 is the only form that lacks a basic heparinbinding region and is freely diffusible. Mouse embryos expressing only the corresponding isoform (VEGF120) do not survive to term, and show defects in skeletogenesis. Human VEGF121 shares 87% aa sequence identity with corresponding regions of mouse and rat, 93% with feline, equine and bovine, and 91%, 95% and 96% with ovine, canine and porcine VEGF, respectively. VEGF121 induces the proliferation of lymphatic endothelial cells. The lymphangiogenesis may be promoted by upregulation of VEGF121, which may in turn act in part via induction of VEGF-C.